Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

Patrick A. Ott, Yung Jue Bang, Dominique Berton-Rigaud, Elena Elez, Michael J. Pishvaian, Hope S. Rugo, Igor Puzanov, Janice M. Mehnert, Kyaw L. Aung, Juanita Lopez, Marion Carrigan, Sanatan Saraf, Mei Chen, Jean Charles Soria

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)26-27
Number of pages2
JournalObstetrical and Gynecological Survey
Volume73
Issue number1
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this